AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gliclastar-M 60 Tablet

Prescription Icon
Prescription Required

Marketer

Zinnia Life Sciences

Salt Composition

Gliclazide (60mg) + Metformin (500mg)

Overview Gliclastar-M 60 Tablet

Diabetol Duo 60mg tablets are antidiabetic medications combining two active ingredients for adult type 2 diabetes management. This dual-action formulation helps regulate blood glucose. Consume Diabetol Duo with meals, consistently at the same time daily for optimal results. Dosage is determined by your physician and may adjust based on your blood sugar response. Continuous use is crucial, even with controlled glucose levels; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan, including a healthy diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are key to diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol should be avoided due to increased hypoglycemia risk. Other possible side effects are altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections; weight gain may also occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Prior heart disease should be disclosed to your doctor before initiating treatment. Pregnant or lactating women should seek medical advice. Regular blood glucose monitoring and blood tests (blood cell counts, liver function) may be recommended by your doctor.

Uses of Gliclastar-M 60 Tablet

Diabetes mellitus type 2

Major Benefits of Gliclastar-M 60 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Gliclastar-M 60 Tablet with a meal.

Common Side effects of Gliclastar-M 60 Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Gliclastar-M 60 Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Gliclastar-M 60mg tablets should be administered with a meal.

How Gliclastar-M 60 Tablet works:

Gliclazide and metformin are combined in the Gliclastar-M 60 Tablet, a dual-action antidiabetic medication.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Gliclastar-M 60 Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Gliclastar-M 60 Tablet during pregnancy poses a confirmed risk to the fetus. Its use should be avoided except in potentially life-threatening circumstances where a physician deems the potential benefits outweigh the known hazards. Always seek medical advice before using this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Gliclastar-M 60 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Gliclastar-M 60 Tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. Gliclastar-M 60 Tablets are contraindicated in patients with severe kidney disease. Routine monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Gliclastar-M 60 Tablet cautiously, potentially requiring dosage modification. A physician's consultation is advised. In those with mild to moderate hepatic dysfunction, Gliclastar-M 60 Tablet is typically initiated at a reduced dosage; however, its administration is contraindicated in cases of severe liver disease.

What if you forget to take Gliclastar-M 60 Tablet :

Should you forget a dose of Gliclastar-M 60 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Gliclastar-M 60 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Gliclastar-M 60 Tablet

Gliclastar-M 60 Tablet combines gliclazide and metformin to manage type 2 diabetes mellitus in adults. It enhances blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 diabetes.
Gliclastar-M 60 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, can also occur. Prolonged use may result in vitamin B12 deficiency.
Gliclastar-M 60 Tablet can cause hypoglycemia (low blood sugar), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. This risk increases with skipped meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Gliclastar-M 60 Tablet can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). This rare side effect is less likely in patients without kidney disease, those who are younger, and those who don't consume large amounts of alcohol. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Gliclastar-M 60 Tablet and seek immediate medical attention.
Prolonged Gliclastar-M 60 Tablet use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Gliclastar-M 60 Tablet is contraindicated in patients with allergies to its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Gliclastar-M 60 Tablet and alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Gliclastar-M 60 Tablet combines gliclazide and metformin to manage type 2 diabetes mellitus in adults. It enhances blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 diabetes.
Gliclastar-M 60 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Gliclastar-M 60 Tablet can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or use with other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Gliclastar-M 60 Tablet can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). This rare side effect is preventable by avoiding use in patients with kidney disease, older adults, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Gliclastar-M 60 Tablet and seek immediate medical attention.
Prolonged Gliclastar-M 60 Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Gliclastar-M 60 Tablet is contraindicated in patients allergic to its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining Gliclastar-M 60 Tablet and alcohol is unsafe. This combination can dangerously lower blood sugar and raise the risk of lactic acidosis.
Gliclastar-M 60 Tablet
40
MRP 46
13% off